SkyOak Wealt »

Catalyst Pharmaceutical Partners shares owned by SkyOak Wealt

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by SkyOak Wealt from 13F filings

Historical chart of SkyOak Wealt investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by SkyOak Wealt consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by SkyOak Wealt

Quarter filed Position value Share count Share price at filing
2026-03-31 $303k 12k 24.76

More positions owned by SkyOak Wealt

Spdr Series Trust State Street Spd (SPYV)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Apple (AAPL)
Ishares Tr Core S&p Us Vlu (IUSV)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr 7-10 Yr Trsy Bd (IEF)
Eli Lilly & Co. (LLY)
Spdr Series Trust State Street Spd (SPYM)
J P Morgan Exchange Traded F Short Dura Core (JSCP)
Select Sector Spdr Tr State Street Tec (XLK)
Blackrock Etf Trust Ishares Us Equit (DYNF)
J P Morgan Exchange Traded F Income Etf (JPIE)
Ishares Tr Core S&p Scp Etf (IJR)
JPMorgan Chase & Co. (JPM)

View all positions for SkyOak Wealt

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
Vanguard Group
State Street Corporation
Vanguard Capital Management
Deerfield Management Company
Dimensional Fund Advisors
Fundsmith
Bank of America Corporation
American Century Companies
Geode Capital Management
Morgan Stanley
Renaissance Technologies
Vanguard Portfolio Management
Royce & Associates
Henderson Group

View all funds holding Catalyst Pharmaceutical Partners